Proposed Data Collections Submitted for Public Comment and Recommendations, 68780-68782 [2012-27835]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
68780
Federal Register / Vol. 77, No. 222 / Friday, November 16, 2012 / Notices
Date Revoked: October 10, 2012.
Reason: Voluntary surrender of
license.
License No.: 020442N.
Name: JWJ Express Inc.
Address: 149–23 182nd Street, Suite
100, Jamaica, NY 11413.
Date Revoked: October 23, 2012.
Reason: Voluntary surrender of
license.
License No.: 015574N.
Name: WW Messenger & Shipping Co.
Address: 150 Main Street, Unit 9,
Orange, NJ 07050.
Date Revoked: October 15, 2012.
Reason: Failed to maintain a valid
bond.
License No.: 019370F.
Name: Cheryl G. Wilson dba JC
Logistics.
Address: 28612 Redondo Beach Drive
South, Des Moines, WA 98198.
Date Revoked: October 23, 2012.
Reason: Voluntary surrender of
license.
License No.: 019480NF.
Name: Intrans Logistics, Inc.
Address: 77 Paloma Avenue, Suite 33,
Pacifica, CA 94044.
Date Revoked: October 5, 2012.
Reason: Failed to maintain valid
bonds.
License No.: 019599F.
Name: Trans Global Services, L.L.C.
Address: 1600 Wilson Blvd., Suite
1210, Arlington, VA 22209.
Date Revoked: October 15, 2012.
Reason: Voluntary surrender of
license.
License No.: 022069N.
Name: Unique Logistics International
(ATL) LLC.
Address: 510 Plaza Drive, Suite 2290,
Atlanta, GA 30349.
Date Revoked: October 15, 2012.
Reason: Failed to maintain a valid
bond.
License No.: 022136N.
Name: Sterling Logistics Group, LLC.
Address: 18 Augusta Pines Drive,
Suite 283–W, Spring, TX 77389.
Date Revoked: October 14, 2012.
Reason: Failed to maintain a valid
bond.
License No.: 022330NF.
Name: Fluent Logistics LLC.
Address: 4770 Highway 165, Meggett,
SC 29449.
Date Revoked: October 19, 2012.
Reason: Failed to maintain valid
bonds.
License No.: 022432N.
Name: Acher and Chex International,
LLC.
Address: 123 Polaris Drive,
Walkersville, MD 27193.
Date Revoked: September 19, 2012.
VerDate Mar<15>2010
15:43 Nov 15, 2012
Jkt 229001
Reason: Failed to maintain a valid
bond.
License No.: 022554F.
Name: Saheed Olalekan Bello dba
Sahbell International Services.
Address: 8180 Southwest Freeway,
Houston, TX 77074.
Date Revoked: October 7, 2012.
Reason: Failed to maintain a valid
bond.
License No.: 023553NF.
Name: Airbridge Corp.
Address: 22 Stonehurst Lane, Dix
Hills, NY 11746.
Date Revoked: October 17, 2012.
Reason: Failed to maintain valid
bonds.
Vern W. Hill,
Director, Bureau of Certification and
Licensing.
[FR Doc. 2012–27967 Filed 11–15–12; 8:45 am]
BILLING CODE 6730–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting Notice for the President’s
Advisory Council on Faith-Based and
Neighborhood Partnerships
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the President’s
Advisory Council on Faith-based and
Neighborhood Partnerships announces
the following meeting:
Name: President’s Advisory Council on
Faith-based and Neighborhood Partnerships
Council Meeting.
Dates: Time and Date: Thursday,
November 29th 10 a.m.–1:00 p.m. (EST).
Place: Meeting will be held at a location to
be determined in the White House complex,
1600 Pennsylvania Ave. NW., Washington,
DC. Space is extremely limited. Photo ID and
RSVP are required to attend the event. Please
RSVP to Ben O’Dell at partnerships@hhs.gov.
Status: Open to the public, limited only by
space available.
Purpose: The Council brings together
leaders and experts in fields related to the
work of faith-based and neighborhood
organizations in order to: Identify best
practices and successful modes of delivering
social services; evaluate the need for
improvements in the implementation and
coordination of public policies relating to
faith-based and other neighborhood
organizations; and make recommendations
for changes in policies, programs, and
practices.
Contact Person for Additional Information:
Please contact Ben O’Dell for any additional
information about the President’s Advisory
Council meeting at partnerships@hhs.gov.
Agenda: Please visit https://
www.whitehouse.gov/partnerships for further
updates on the Agenda for the meeting.
Public Comment: There will be an
opportunity for public comment at the end of
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
the meeting. Comments and questions can be
sent in advance to partnerships@hhs.gov.
Dated: November 9, 2012.
Ben O’Dell,
Designated Federal Officer and Associate
Director, HHS Center for Faith-based and
Neighborhood Partnerships.
[FR Doc. 2012–27855 Filed 11–15–12; 8:45 am]
BILLING CODE 4154–07–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60-Day–13–13BF]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 and
send comments to Ron Otten, at CDC
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an email to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Spectrum of Flavoring ChemicalRelated Lung Disease—New—National
Institute for Occupational Safety and
Health (NIOSH), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The mission of the National Institute
for Occupational Safety and Health
(NIOSH) is to promote safety and health
at work for all people through research
E:\FR\FM\16NON1.SGM
16NON1
68781
Federal Register / Vol. 77, No. 222 / Friday, November 16, 2012 / Notices
and prevention. The Occupational
Safety and Health Act, Public Law 91–
596 (section 20[a][1]), authorizes NIOSH
to conduct research to advance the
health and safety of workers. NIOSH is
proposing to conduct a study
characterizing the nature of restrictive
lung disease occurring in flavoring and
microwave popcorn workers.
Preliminary evidence suggests that
flavorings exposures may be associated
with restrictive lung disease in exposed
workers. In two previous NIOSH health
hazard evaluations, we found excesses
of restrictive spirometry among workers
in a flavoring manufacturing plant and
a flavoring-exposed food production
plant. There was virtually no
obstructive lung disease in either of
these health hazard evaluations. Over
the course of eight cross-sectional
studies at a microwave popcorn plant,
we also found strong relationships
between decreases in FEV1 and
cumulative exposure estimates, without
differentiating between obstructive and
restrictive abnormalities.
NIOSH requests OMB approval to
collect additional information on a
subset of participants from previous
NIOSH studies to determine if
restrictive lung disease is occurring
among flavoring and popcorn workers.
Diagnostic methods for restrictive lung
disease will be applied in field settings.
This will include spirometry, lung
volume testing such as total lung
capacity (TLC) and diffusing capacity of
the lung to carbon monoxide (DLCO), as
well as high resolution computed
tomography (HRCT), which can detect
lung abnormalities consistent with
interstitial lung disease. These medical
tests are critical to establishing lung
disease of a fibrotic or inflammatory
nature in persons with spirometric
restriction.
Recent literature has demonstrated
that bronchiolitis obliterans and
obstructive lung disease are related to
flavoring exposures in an exposuredependent way. However, secondary
prevention of further impairment among
flavoring workers with spirometric
restriction and excessive declines in
lung function of a restrictive nature is
not occurring. Flavoring workers with
restrictive abnormalities are not
identified as having possible
occupational lung disease, are not
removed from further flavorings
exposure, are not counseled about
respiratory protection and work
practices, and are unlikely to be
successful in claims for work-related
lung disease and medical expenses.
These cases of restrictive spirometric
abnormality do not motivate employers
to implement controls to prevent lung
injury to co-workers or to enhance
medical surveillance programs.
Results from this study will benefit
many stakeholders, including
physicians who can appropriately
manage workers with restrictive lung
disease with consideration of enhanced
respiratory protection or reassignment;
workers who can make decisions
regarding continued exposures and
apply for compensation if warranted;
companies who can set data driven
priorities for preventive interventions;
and policy makers who can recommend
measures to prevent flavoring-related
lung diseases.
For this study, we will recruit
participants from two study
populations: approximately 100 workers
from a flavorings plant for whom we
have spirometry data and 130 workers
that had abnormal spirometry on any
test from a previous NIOSH health
hazard evaluation at a microwave
popcorn plant. Thirty additional
workers from the microwave popcorn
plant who had normal spirometry on
their last test also will be chosen at
random.
NIOSH anticipates that information
collection will begin during the summer
of 2013 for the microwave popcorn
workers and for the flavorings workers
in the summer of 2014. Both study
populations will be offered a
questionnaire, spirometry, TLC test,
DLCO, and HRCT of the chest. Those
with abnormal spirometry will also be
offered a bronchodilator test. Testing is
expected to take between 3 to 3.25 hours
per respondent. All testing will be
conducted by trained NIOSH personnel,
except for the HRCT chest scan, which
will be done at a local hospital or
radiology clinic. Participants will
receive a letter which will explain their
testing results. All study results will be
stored at NIOSH.
The total estimated burden for the
one-time collection of data is 822 hours.
This is an overestimate of the actual
burden to account for any possible
waiting at the radiology clinic.
Participation in this study is voluntary,
and there are no costs to respondents
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Popcorn workers with normal
spirometry.
Popcorn workers with abnormal
spirometry.
Flavoring workers with normal
spirometry.
Flavoring workers with abnormal
spirometry.
mstockstill on DSK4VPTVN1PROD with NOTICES
Total ..........................................
VerDate Mar<15>2010
15:43 Nov 15, 2012
Number of
respondents
Testing
Questionnaire Spirometry
TLC HRCT.
Questionnaire Spirometry
TLC HRCT Bronchodilator
Questionnaire Spirometry
TLC HRCT.
Questionnaire Spirometry
TLC HRCT Bronchodilator
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
DLCO
30
1
3
DLCO
test.
DLCO
130
1
3.25
423
64
1
3
192
DLCO
test.
36
1
3.25
117
..........................................................
........................
........................
..........................
822
Jkt 229001
PO 00000
Frm 00051
Fmt 4703
Sfmt 9990
E:\FR\FM\16NON1.SGM
16NON1
90
68782
Federal Register / Vol. 77, No. 222 / Friday, November 16, 2012 / Notices
Dated:November 2, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity OSI),
Office of the Associate Director for Science
OADS), Office of the Director, Centers for
Disease Control and Prevention.
produce a set of sensitive indicators.
This surveillance will continue to
provide the evidence to enhance our
understanding of STDs, develop
intervention strategies, and evaluate the
impact of ongoing control efforts. CDC
works closely with state and local STD
control programs to monitor and
respond to STD outbreaks and trends in
STD-associated risk behavior. Users of
data include, but are not limited to,
congressional offices, state and local
health agencies, health care providers,
and other health-related groups.
CDC disseminates all STD
surveillance information through the
MMWR series of publications, including
the MMWR, the CDC Surveillance
Summaries, the Recommendations and
Reports, and the annual Summary of
Notifiable Diseases, United States.
Additionally, DSTDP publishes an
annual STD-specific surveillance
summary and supplements in hard copy
and on the Internet https://www.cdc.gov/
std/Stats/. CDC will use the findings
from this and other STD surveillance to
develop guidelines, control strategies,
and impact measures that monitor
trends in STDs in the United States. We
expect a total of 57 sites in state, city,
and territory health departments will be
submitting STD morbidity information
to CDC each week.
There is no cost to respondents other
than their time. The total estimated
annualized burden hours are 989.
Proposed Project
Nationally Notifiable Sexually
Transmitted Disease (STD) Morbidity
Surveillance (OMB No. 0920–0819,
Expiration 08/31/2012)—Reinstatement
with Change—National Center for HIV,
Viral Hepatitis, STD and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
[FR Doc. 2012–27835 Filed 11–15–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–13–0819]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Background and Brief Description
Because the STD epidemiology in the
United States is changing rapidly, CDC
must continue to monitor disease
indicators that are included in the STD
surveillance currently being
implemented. CDC is proposing to
continue electronic information
collection which includes information
elements that are integrated into the
existing nationally notifiable STDs.
These information elements are beyond
the scope of the OMB-approved
collection called Weekly and Annual
Morbidity and Mortality Reports
(MMWR, OMB #0920–0007). This
ongoing collection will have a title
change from ‘‘Sexually Transmitted
Disease (STD) Morbidity Surveillance’’
to ‘‘Nationally Notifiable Sexually
Transmitted Disease (STD) Morbidity
Surveillance and provides evidence to
better define STD distribution and
epidemiology in the United States. The
surveillance system modifies several
data elements currently included in the
MMWR collection and add others to
ESTIMATE OF ANNUALIZED BURDEN TABLE
Number of
respondents
Types of respondent
Form name
State Health Departments ..............................
Territorial Health Agencies .............................
City and county health departments ...............
Electronic STD Case report ...........................
Electronic STD Case report ...........................
Electronic STD Case report ...........................
Dated: November 2, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science
(OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2012–27832 Filed 11–15–12; 8:45 am]
mstockstill on DSK4VPTVN1PROD with NOTICES
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Breast Cancer
in Young Women (ACBCYW)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 9:30 a.m.–3:30 p.m. EST,
December 13, 2012.
Place: The meeting will be held via
teleconference.
VerDate Mar<15>2010
15:43 Nov 15, 2012
Jkt 229001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
50
5
2
Number of
responses per
respondent
52
52
52
Average
burden per
response
(in hours)
20/60
20/60
20/60
Teleconference login information is as
follows:
For Public:
TOLL-FREE PHONE #: 800–857–4875.
Participant passcode: 9377.
Net Conference URL: https://
www.mymeetings.com/nc/join/.
Conference number: PW6978681.
Audience passcode: 9377, or
Public can join the event directly:
https://www.mymeetings.com/nc/
join.php?i=PW6978681&p=9377&t=c.
There is also a toll number for anyone
outside of the USA:
TOLL # 1–212–287–1661.
Participant passcode: 9377.
Please go to the ACBCYW meeting Web
page to register for this meeting:
https://www.cdc.gov/cancer/breast/
what_cdc_is_doing/conference.htm.
E:\FR\FM\16NON1.SGM
16NON1
]]>Agencies
[Federal Register Volume 77, Number 222 (Friday, November 16, 2012)]
[Notices]
[Pages 68780-68782]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-27835]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60-Day-13-13BF]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570
and send comments to Ron Otten, at CDC 1600 Clifton Road, MS-D74,
Atlanta, GA 30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Spectrum of Flavoring Chemical-Related Lung Disease--New--National
Institute for Occupational Safety and Health (NIOSH), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The mission of the National Institute for Occupational Safety and
Health (NIOSH) is to promote safety and health at work for all people
through research
[[Page 68781]]
and prevention. The Occupational Safety and Health Act, Public Law 91-
596 (section 20[a][1]), authorizes NIOSH to conduct research to advance
the health and safety of workers. NIOSH is proposing to conduct a study
characterizing the nature of restrictive lung disease occurring in
flavoring and microwave popcorn workers.
Preliminary evidence suggests that flavorings exposures may be
associated with restrictive lung disease in exposed workers. In two
previous NIOSH health hazard evaluations, we found excesses of
restrictive spirometry among workers in a flavoring manufacturing plant
and a flavoring-exposed food production plant. There was virtually no
obstructive lung disease in either of these health hazard evaluations.
Over the course of eight cross-sectional studies at a microwave popcorn
plant, we also found strong relationships between decreases in FEV1 and
cumulative exposure estimates, without differentiating between
obstructive and restrictive abnormalities.
NIOSH requests OMB approval to collect additional information on a
subset of participants from previous NIOSH studies to determine if
restrictive lung disease is occurring among flavoring and popcorn
workers. Diagnostic methods for restrictive lung disease will be
applied in field settings. This will include spirometry, lung volume
testing such as total lung capacity (TLC) and diffusing capacity of the
lung to carbon monoxide (DLCO), as well as high resolution computed
tomography (HRCT), which can detect lung abnormalities consistent with
interstitial lung disease. These medical tests are critical to
establishing lung disease of a fibrotic or inflammatory nature in
persons with spirometric restriction.
Recent literature has demonstrated that bronchiolitis obliterans
and obstructive lung disease are related to flavoring exposures in an
exposure-dependent way. However, secondary prevention of further
impairment among flavoring workers with spirometric restriction and
excessive declines in lung function of a restrictive nature is not
occurring. Flavoring workers with restrictive abnormalities are not
identified as having possible occupational lung disease, are not
removed from further flavorings exposure, are not counseled about
respiratory protection and work practices, and are unlikely to be
successful in claims for work-related lung disease and medical
expenses. These cases of restrictive spirometric abnormality do not
motivate employers to implement controls to prevent lung injury to co-
workers or to enhance medical surveillance programs.
Results from this study will benefit many stakeholders, including
physicians who can appropriately manage workers with restrictive lung
disease with consideration of enhanced respiratory protection or
reassignment; workers who can make decisions regarding continued
exposures and apply for compensation if warranted; companies who can
set data driven priorities for preventive interventions; and policy
makers who can recommend measures to prevent flavoring-related lung
diseases.
For this study, we will recruit participants from two study
populations: approximately 100 workers from a flavorings plant for whom
we have spirometry data and 130 workers that had abnormal spirometry on
any test from a previous NIOSH health hazard evaluation at a microwave
popcorn plant. Thirty additional workers from the microwave popcorn
plant who had normal spirometry on their last test also will be chosen
at random.
NIOSH anticipates that information collection will begin during the
summer of 2013 for the microwave popcorn workers and for the flavorings
workers in the summer of 2014. Both study populations will be offered a
questionnaire, spirometry, TLC test, DLCO, and HRCT of the chest. Those
with abnormal spirometry will also be offered a bronchodilator test.
Testing is expected to take between 3 to 3.25 hours per respondent. All
testing will be conducted by trained NIOSH personnel, except for the
HRCT chest scan, which will be done at a local hospital or radiology
clinic. Participants will receive a letter which will explain their
testing results. All study results will be stored at NIOSH.
The total estimated burden for the one-time collection of data is
822 hours. This is an overestimate of the actual burden to account for
any possible waiting at the radiology clinic. Participation in this
study is voluntary, and there are no costs to respondents other than
their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Testing Number of responses per per response Total burden
respondents respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
Popcorn workers with normal Questionnaire 30 1 3 90
spirometry. Spirometry DLCO
TLC HRCT.
Popcorn workers with abnormal Questionnaire 130 1 3.25 423
spirometry. Spirometry DLCO
TLC HRCT
Bronchodilator
test.
Flavoring workers with normal Questionnaire 64 1 3 192
spirometry. Spirometry DLCO
TLC HRCT.
Flavoring workers with Questionnaire 36 1 3.25 117
abnormal spirometry. Spirometry DLCO
TLC HRCT
Bronchodilator
test.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 822
----------------------------------------------------------------------------------------------------------------
[[Page 68782]]
Dated:November 2, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity OSI), Office of the Associate
Director for Science OADS), Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012-27835 Filed 11-15-12; 8:45 am]
BILLING CODE 4163-18-P
